GYRE
Gyre Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
GYRE fundamentals
Gyre Therapeutics (GYRE) expects to report earnings on Aug 12, 2025, with estimated revenue of 30.80M (YoY +22.10%), and EPS at -- (YoY 0.00%).
Revenue estimate / YoY
30.80M
+22.10%
EPS estimate / YoY
--
0.00%
Report date
Aug 12, 2025
EPS
Revenue
Revenue & Expenses
GYRE has released its 2025 Q1 earnings report, with revenue of 22.06M, reflecting a YoY change of -18.82%, and net profit of 3.73M, showing a YoY change of -62.42%. The Sankey diagram below clearly presents GYRE's revenue sources and cost distribution.
Key Indicators
Gyre Therapeutics (GYRE) key financial stats and ratios, covering profitability, financial health, and leverage.
Gyre Therapeutics (GYRE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Gyre Therapeutics (GYRE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Gyre Therapeutics (GYRE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Gyre Therapeutics (GYRE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Gyre Therapeutics (GYRE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market’s earnings forecast for Gyre Therapeutics next quarter?Did Gyre Therapeutics beat or miss consensus estimates last quarter?What is Gyre Therapeutics’s latest dividend and current dividend yield?What guidance did Gyre Therapeutics’s management provide for the next earnings period? What is the revenue and EPS growth rate for Gyre Therapeutics year over year?How were Gyre Therapeutics’s latest financial results overall?What were the key takeaways from Gyre Therapeutics’s earnings call?What is Gyre Therapeutics’s gross profit margin?